$DELC recently announced that it has acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures Ltd., a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Following closing, CBDV will change its name to "DELIC Labs" and will serve as the engine for the Delic platform, conducting research and developing innovative product lines and intellectual property, including psilocybin vaporization technology for future distribution across the company's physical footprint.
Matt Stang, $DELC Co-Founder and CEO commented, "CBDV has a consistently profitable history, more than 50 blue chip clients, and an opportunity for tremendous growth as we commercialize the science. As further legalization of psychedelic treatments progresses, we are well positioned to capitalize on new markets with significant opportunities.”
$DELC is looking great up 1.6% , current MC is $11.87M.
More here
https://www.newswire.ca/news-releases/leading-psychedelic-wellness-platform-delic-completes-acquisition-of-complex-biotech-discovery-ventures-ltd--849036510.html